Novo Nordisk Aktie
46,06
EUR
+0,15
EUR
+0,32
%
45,94
EUR
-0,23
EUR
-0,50
%
Werbung
Novo Nordisk Aktie Analyse
| 12.04.23 | Novo Nordisk Overweight | Barclays Capital | |
| 11.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 06.04.23 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 03.04.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 22.03.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 14.03.23 | Novo Nordisk Buy | Deutsche Bank AG | |
|
Werbung
|
|||
| 09.03.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 22.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 13.02.23 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 06.02.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 02.02.23 | Novo Nordisk Neutral | Credit Suisse Group | |
| 02.02.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 01.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.02.23 | Novo Nordisk Sell | UBS AG | |
| 01.02.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 25.01.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 25.01.23 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 25.01.23 | Novo Nordisk Overweight | Barclays Capital | |
| 20.01.23 | Novo Nordisk Sell | UBS AG | |
| 16.01.23 | Novo Nordisk Buy | Deutsche Bank AG | |
| 09.01.23 | Novo Nordisk Overweight | Barclays Capital | |
| 09.01.23 | Novo Nordisk Sell | UBS AG | |
| 05.01.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.01.23 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 23.12.22 | Novo Nordisk Overweight | Barclays Capital | |
| 07.12.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 25.11.22 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 14.11.22 | Novo Nordisk Overweight | Barclays Capital | |
| 08.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 04.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 03.11.22 | Novo Nordisk Neutral | Credit Suisse Group | |
| 03.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.11.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 02.11.22 | Novo Nordisk Sell | UBS AG | |
| 02.11.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 02.11.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 24.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 14.10.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 14.10.22 | Novo Nordisk Overweight | Barclays Capital | |
| 07.10.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 04.10.22 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 03.10.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 03.10.22 | Novo Nordisk Overweight | Barclays Capital | |
| 21.09.22 | Novo Nordisk Buy | Deutsche Bank AG | |
| 23.08.22 | Novo Nordisk Sell | UBS AG | |
| 22.08.22 | Novo Nordisk Overweight | JP Morgan Chase & Co. | |
| 17.08.22 | Novo Nordisk Sell | UBS AG | |
| 15.08.22 | Novo Nordisk Overweight | Barclays Capital | |
Werbung
Werbung